| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1365-2958.1996.00074.X |
| P698 | PubMed publication ID | 8898390 |
| P2093 | author name string | D A Portnoy | |
| S Jones | |||
| K Preiter | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1219-1225 | |
| P577 | publication date | 1996-09-01 | |
| P1433 | published in | Molecular Microbiology | Q6895967 |
| P1476 | title | Conversion of an extracellular cytolysin into a phagosome-specific lysin which supports the growth of an intracellular pathogen | |
| P478 | volume | 21 |
| Q39521899 | Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death |
| Q47105902 | Carboxyl-Terminal Residues N478 and V479 Required for the Cytolytic Activity of Listeriolysin O Play a Critical Role in Listeria monocytogenes Pathogenicity |
| Q34033192 | Characterization of Listeria monocytogenes expressing anthrolysin O and phosphatidylinositol-specific phospholipase C from Bacillus anthracis |
| Q57976656 | Critical role of the N-terminal residues of listeriolysin O in phagosomal escape and virulence ofListeria monocytogenes |
| Q41395779 | Cytolysins and the intracellular life of bacteria |
| Q34208868 | Development of a single-gene, signature-tag-based approach in combination with alanine mutagenesis to identify listeriolysin O residues critical for the in vivo survival of Listeria monocytogenes |
| Q79149338 | Enhanced immunogenicity of SIV Gag DNA vaccines encoding chimeric proteins containing a C-terminal segment of Listeriolysin O |
| Q34159330 | Episomal expression of truncated listeriolysin O in LmddA-LLO-E7 vaccine enhances antitumor efficacy by preferentially inducing expansions of CD4+FoxP3- and CD8+ T cells |
| Q33957678 | Exploiting the immune system: toward new vaccines against intracellular bacteria |
| Q33999918 | Expression of listeriolysin O and ActA by intracellular and extracellular Listeria monocytogenes |
| Q34134510 | From evil to good: a cytolysin in vaccine development. |
| Q34319724 | Inducible control of virulence gene expression in Listeria monocytogenes: temporal requirement of listeriolysin O during intracellular infection |
| Q24680571 | Listeria monocytogenes exploits normal host cell processes to spread from cell to cell |
| Q33975740 | Listeria pathogenesis and molecular virulence determinants |
| Q24672984 | Listeriolysin O: a genuine cytolysin optimized for an intracellular parasite |
| Q33765637 | Modulation of enzymatic activity and biological function of Listeria monocytogenes broad-range phospholipase C by amino acid substitutions and by replacement with the Bacillus cereus ortholog |
| Q27023593 | More than a pore: the cellular response to cholesterol-dependent cytolysins |
| Q39842246 | Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis |
| Q33877458 | Novel recombinant Mycobacterium bovis BCG, ovine atadenovirus, and modified vaccinia virus Ankara vaccines combine to induce robust human immunodeficiency virus-specific CD4 and CD8 T-cell responses in rhesus macaques |
| Q36254723 | Proteolytic pathways of activation and degradation of a bacterial phospholipase C during intracellular infection by Listeria monocytogenes |
| Q54564874 | TAP‐dependent major histocompatibility complex class I presentation of soluble proteins using listeriolysin |
| Q40940085 | The smcL gene of Listeria ivanovii encodes a sphingomyelinase C that mediates bacterial escape from the phagocytic vacuole. |
| Q41632691 | Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae. |
Search more.